Bora Pharmaceuticals Co., LTD. (6472.TW)

TWD 675.0

(3.05%)

EBITDA Summary of Bora Pharmaceuticals Co., LTD.

  • Bora Pharmaceuticals Co., LTD.'s latest annual EBITDA in 2023 was 5.73 Billion TWD , up 112.92% from previous year.
  • Bora Pharmaceuticals Co., LTD.'s latest quarterly EBITDA in 2024 Q2 was 1.1 Billion TWD , down -21.19% from previous quarter.
  • Bora Pharmaceuticals Co., LTD. reported an annual EBITDA of 2.27 Billion TWD in 2022, up 76.58% from previous year.
  • Bora Pharmaceuticals Co., LTD. reported an annual EBITDA of 1.28 Billion TWD in 2021, up 247.53% from previous year.
  • Bora Pharmaceuticals Co., LTD. reported a quarterly EBITDA of 1.2 Billion TWD for 2024 Q1, up 33.68% from previous quarter.
  • Bora Pharmaceuticals Co., LTD. reported a quarterly EBITDA of 1.2 Billion TWD for 2023 Q2, down -25.71% from previous quarter.

Annual EBITDA Chart of Bora Pharmaceuticals Co., LTD. (2023 - 2019)

Historical Annual EBITDA of Bora Pharmaceuticals Co., LTD. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 5.73 Billion TWD 112.92%
2022 2.27 Billion TWD 76.58%
2021 1.28 Billion TWD 247.53%
2020 370.53 Million TWD -18.03%
2019 452.03 Million TWD 0.0%

Peer EBITDA Comparison of Bora Pharmaceuticals Co., LTD.

Name EBITDA EBITDA Difference
Grape King Bio Ltd 2.88 Billion TWD -98.763%
Standard Chem & Pharm CO., LTD. 1.57 Billion TWD -263.163%
Maywufa Company Ltd. 239.81 Million TWD -2291.125%
ScinoPharm Taiwan, Ltd. 819.15 Million TWD -600.021%
Lotus Pharmaceutical Co., Ltd. 6.87 Billion TWD 16.544%
LIWANLI Innovation Co., Ltd. 6.81 Million TWD -84103.407%
YungShin Global Holding Corporation 1.35 Billion TWD -322.455%
PhytoHealth Corporation -20.69 Million TWD 27804.377%
SCI Pharmtech, Inc. 529.61 Million TWD -982.725%
Formosa Laboratories, Inc. 1.16 Billion TWD -392.928%
PharmaEssentia Corporation -671.48 Million TWD 953.964%